Search

Search Constraints

You searched for: Author/Creator Rule, Simon

Search Results

2. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017)

4. A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL. Issue 4 (9th September 2019)

6. Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial. Issue 10121 (17th February 2018)

7. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study. Issue 2 (February 2020)

10. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018)